Other Species / Isoforms
  SPRY1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S40
IQPTAILSLDQIkAI
0 1
SPRY1 (human) IQPTAILSLDQIkAI S40
SPRY1 (mouse) TQPATILsLDQIKAI S40-p
SPRY1 (rat) TQPATILSLDQIKAI S40
K45-ub
ILSLDQIkAIRGsNE
0 1
SPRY1 (human) ILSLDQIkAIRGsNE K45-ub
SPRY1 (mouse) ILsLDQIKAIRGsNE K45
SPRY1 (rat) ILSLDQIKAIRGSNE K45
S50-p
QIkAIRGsNEytEGP
0 3
SPRY1 (human) QIkAIRGsNEytEGP S50-p
SPRY1 (mouse) QIKAIRGsNEyTEGP S50-p
SPRY1 (rat) QIKAIRGSNEYTEGP S50
Y53-p
AIRGsNEytEGPSVV
Upstream
Downstream
3 250
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • signaling pathway regulation
Phosphatases, in vitro:
  • SHP-2 (human)
Putative upstream phosphatases:
  • SHP-2 (human)
Treatment
  • erlotinib
  • FGF2
  • gefitinib
  • Su11274
view more >
SPRY1 (human) AIRGsNEytEGPSVV Y53-p
SPRY1 (mouse) AIRGsNEyTEGPSVA Y53-p
SPRY1 (rat) AIRGSNEYTEGPSVA Y53
T54-p
IRGsNEytEGPSVVK
0 3
SPRY1 (human) IRGsNEytEGPSVVK T54-p
SPRY1 (mouse) IRGsNEyTEGPSVAR T54
SPRY1 (rat) IRGSNEYTEGPSVAR T54
Y89-p
PINVNNNyEHRHTSH
0 54
SPRY1 (human) PINVNNNyEHRHTSH Y89-p
SPRY1 (mouse) PANVNSSYEHRPASH Y89
SPRY1 (rat) PANVNSSYVHRPAGH Y89
S112-p
NARGPILsRSTSTGS
0 1
SPRY1 (human) NARGPILsRSTSTGS S112-p
SPRY1 (mouse) NARGSVLSRSTSTGS S106
SPRY1 (rat) NARGSVLSRSTSTGS S106
S123-p
STGSAASsGSNSSAS
0 2
SPRY1 (human) STGSAASsGSNSSAS S123-p
SPRY1 (mouse) STGSAASSGSSSSVS S117
SPRY1 (rat) STGSAASsGSSsSVS S117-p
S127
AASsGSNSSASsEQG
0 1
SPRY1 (human) AASsGSNSSASsEQG S127
SPRY1 (mouse) AASSGSSSSVSSEQG S121
SPRY1 (rat) AASsGSSsSVSSEQG S121-p
S131-p
GSNSSASsEQGLLGR
0 1
SPRY1 (human) GSNSSASsEQGLLGR S131-p
SPRY1 (mouse) GSSSSVSSEQGLLGR S125
SPRY1 (rat) GSSsSVSSEQGLLGR S125
S139-p
EQGLLGRsPPTRPVP
0 4
SPRY1 (human) EQGLLGRsPPTRPVP S139-p
SPRY1 (mouse) EQGLLGRsPPTRPIP S133-p
SPRY1 (rat) EQGLLGRSPPtRPIP S133
T142
LLGRsPPTRPVPGHR
0 1
SPRY1 (human) LLGRsPPTRPVPGHR T142
SPRY1 (mouse) LLGRsPPTRPIPGHR T136
SPRY1 (rat) LLGRSPPtRPIPGHR T136-p
K167-ub
QLIVDDLkGsLkEDL
0 2
SPRY1 (human) QLIVDDLkGsLkEDL K167-ub
SPRY1 (mouse) QLLVEDLkASLKEDP K161-ub
SPRY1 (rat) QLLVDDLKASLKEDP K161
S169-p
IVDDLkGsLkEDLTQ
0 1
SPRY1 (human) IVDDLkGsLkEDLTQ S169-p
SPRY1 (mouse) LVEDLkASLKEDPTQ S163
SPRY1 (rat) LVDDLKASLKEDPTQ S163
K171-ub
DDLkGsLkEDLTQHK
0 1
SPRY1 (human) DDLkGsLkEDLTQHK K171-ub
SPRY1 (mouse) EDLkASLKEDPTQHK K165
SPRY1 (rat) DDLKASLKEDPTQHK K165
Y304-p
CKNSNTVyCkLESCP
0 8
SPRY1 (human) CKNSNTVyCkLESCP Y304-p
SPRY1 (mouse) CRNSNTVYCKLESCP Y298
SPRY1 (rat) CRNSNTVYCKLESCP Y298
K306-ub
NSNTVyCkLESCPSR
0 1
SPRY1 (human) NSNTVyCkLESCPSR K306-ub
SPRY1 (mouse) NSNTVYCKLESCPSR K300
SPRY1 (rat) NSNTVYCKLESCPSR K300